06.02.2012 • News

AkzoNobel Strengthens its Global MCA Position

AkzoNobel has announced two steps in strengthening its global position in the market of monochloroacetic acid (MCA). Recently it has commissioned its expanded Delfzijl MCA facility in the Netherlands, which now has a capacity exceeding 100,000 mt/year. In parallel, AkzoNobel is to further increase MCA production capacity at its Taixing site in China to also reach a level of 100,000 mt/year.

Jürgen Baune, general manager of AkzoNobel's MCA business, said the company's key focus will be to serve the increasing demand for high purity MCA in main end markets like agrochemicals, carboxymethylcellulose (CMC), surfactants and thioglycolic acid. The company estimates the global MCA market at about 650,000 mt/year.

In addition to the Delfzijl and Taixing plants AkzoNobel operates MCA facilities in the U.S. and in Japan via Denak, a 50/50 joint venture between AkzoNobel and Denki Kagaku Kogyo.

 

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read